Charles Staley, MD

Background

Dr. Charles Staley joined the Emory faculty in 1995 after completing his surgical oncology fellowship at MD Anderson Cancer Center. His clinical practice focuses on surgical treatment of stomach, esophageal, appendiceal, colorectal, and peritoneal surface malignancies. His research focuses on translational studies and novel clinical trials in gastrointestinal cancers. He has investigated gene therapy for metastatic colon cancer, radiofrequency ablation with intra-arterial chemotherapy for patients with colorectal liver metastases, and neoadjuvant chemoradiation with the goal of maximizing sphincter preservation in the treatment of rectal cancer. His current investigations include exploring methods of using nanotechnology to diagnose and treat pancreatic and breast cancer with such colleagues as Dr. Lily Yang.

Dr. Staley coordinates national efforts for clinical cancer research as a principle investigator for clinical trials for the Eastern Cooperative Oncology Group; as chair of the Vizient UHC Cancer Center Network Steering Committee, which oversees a national network of approximately 125 cancer centers nationally; and as co-principal investigator of the Winship Cancer Institute location of the National Cancer Institute's National Clinical Trials Network (NCTN). The NCTN serves as the NCI's primary infrastructure for conducting phase II and phase III cancer clinical trials.

Titles & Roles

• Holland M. Ware Professor of Surgery, Division of Surgical Oncology, Department of Surgery

  Emory University School of Medicine
• Chief, Division of Surgical Oncology

  Winship Cancer Institute of Emory University

Education & Training

Education

• Fellowship, Surgical Oncology, 1995

  Univ of TX M.D. Anderson Cancer Ctr
• Residency, General Surgery, 1992

  Univ of Pittsburgh Medical Center
• Medical Education, MD, 1987

  Dartmouth Medical School

Board Certifications

• Surgery

  American Board of Surgery, 1993

Professional Memberships

• American Surgival Association
• Southern Surgical Association
• Georgia Surgical Society
• Society of Surgical Oncology
• American College of Surgeons

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.